Federated Hermes Portfolio holdings
AUM
$53.1B
1-Year Return
30.23%
This Quarter Return
+7.1%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$51.4B
AUM Growth
+$2.6B
(+5.3%)
Cap. Flow
+$799M
Cap. Flow
% of AUM
1.55%
Top 10 Holdings %
Top 10 Hldgs %
11.68%
Holding
2,449
New
226
Increased
917
Reduced
928
Closed
240
Top Buys
| 1 |
US Bancorp
USB
|
$178M |
| 2 |
Truist Financial
TFC
|
$132M |
| 3 |
BZUN
Baozun
BZUN
|
$98.6M |
| 4 |
Crown Castle
CCI
|
$98.4M |
| 5 |
StepStone Group
STEP
|
$98.1M |
Top Sells
| 1 |
Alibaba
BABA
|
$404M |
| 2 |
Bristol-Myers Squibb
BMY
|
$219M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$213M |
| 4 |
JPMorgan Chase
JPM
|
$167M |
| 5 |
AT&T
T
|
$133M |
Sector Composition
| 1 | Healthcare | 21.42% |
| 2 | Technology | 20.04% |
| 3 | Financials | 11.95% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Cognex
CGNX
$7.43B
| $36.1M | 0.07% |
435,549
+6,582
| +2% | +$546K |
|
352
Revolve Group
RVLV
$1.7B
| $35.9M | 0.07% |
800,000
| – | – |
|
353
Everest Group
EG
$14.3B
| $35.9M | 0.07% |
144,751
+478
| +0.3% | +$118K |
|
354
Copart
CPRT
$47B
| $35.8M | 0.07% |
1,319,300
+177,228
| +16% | +$4.81M |
|
355
DuPont de Nemours
DD
$32.6B
| $35.5M | 0.07% |
459,695
+88,971
| +24% | +$6.88M |
|
356
IDEAYA Biosciences
IDYA
$2.38B
| $35.4M | 0.07% |
1,506,212
+407,864
| +37% | +$9.58M |
|
357
NVR
NVR
$23.5B
| $35.2M | 0.07% |
7,477
+314
| +4% | +$1.48M |
|
|
CFRX
358
DELISTED
ContraFect Corporation
CFRX
| $35M | 0.07% |
91,215
+25,000
| +38% | +$9.6M |
|
|
RUBY
359
DELISTED
Rubius Therapeutics, Inc
RUBY
| $35M | 0.07% |
1,321,355
+721,355
| +120% | +$19.1M |
|
360
CryoPort
CYRX
$518M
| $34.9M | 0.07% |
671,370
-19,700
| -3% | -$1.02M |
|
361
Kraft Heinz
KHC
$32.3B
| $34.9M | 0.07% |
872,409
+168,917
| +24% | +$6.76M |
|
362
Masco
MAS
$15.9B
| $34.8M | 0.07% |
581,254
-18,034
| -3% | -$1.08M |
|
|
AKUS
363
DELISTED
Akouos, Inc. Common Stock
AKUS
| $34.8M | 0.07% |
2,509,682
+190,200
| +8% | +$2.64M |
|
364
NextEra Energy, Inc.
NEE
$146B
| $34.4M | 0.07% |
454,965
+84,181
| +23% | +$6.36M |
|
365
Montrose Environmental
MEG
$1.07B
| $33.9M | 0.07% |
675,000
-10,000
| -1% | -$502K |
|
366
Stoke Therapeutics
STOK
$1.13B
| $33.9M | 0.07% |
872,264
-96,547
| -10% | -$3.75M |
|
367
Commault Systems
CVLT
$7.96B
| $33.5M | 0.07% |
519,328
+81,230
| +19% | +$5.24M |
|
368
Wells Fargo
WFC
$253B
| $33.5M | 0.06% |
856,225
+709,693
| +484% | +$27.7M |
|
369
Jamf
JAMF
$1.22B
| $33.4M | 0.06% |
945,746
-5,835
| -0.6% | -$206K |
|
|
AYX
370
DELISTED
Alteryx, Inc.
AYX
| $33.2M | 0.06% |
400,000
| – | – |
|
371
Exelon
EXC
$43.9B
| $33.1M | 0.06% |
1,060,506
+48,943
| +5% | +$1.53M |
|
372
ConocoPhillips
COP
$116B
| $33.1M | 0.06% |
624,026
+75,001
| +14% | +$3.97M |
|
|
HZNP
373
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $33.1M | 0.06% |
359,094
-139,894
| -28% | -$12.9M |
|
374
UGI
UGI
$7.43B
| $32.6M | 0.06% |
793,779
+10,649
| +1% | +$437K |
|
375
AstraZeneca
AZN
$253B
| $32.5M | 0.06% |
653,738
+6,123
| +0.9% | +$304K |
|